Last Update Time:
07-Mar-2025 16:00:00
ISIN:
INE07RO01027
Sector:
Healthcare
Symbol:
SUPRIYA
Supriya Lifescience Limited
₹640.00
₹11.80
(1.88%)
▲
Prev. Close
₹628.20
Open
₹630.00
Close
₹644.00
Range
₹608.00 - ₹672.00
High
₹661.85
Low
₹626.15
Ind. Close
₹0.00
VWAP
₹642.13
The current stock price of Supriya Lifescience Limited is ₹640.00, with a target price range between ₹608.00 and ₹672.00. The stock has experienced a price change of ₹11.80 (1.88%), reflecting recent market volatility.
Today's opening price was ₹630.00, while the previous close stood at ₹628.20.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Supriya Lifescience Limited Price Chart
Supriya Lifescience Limited Pre Open Market Overview: 07-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 630
- Previous Close Price: 628.2
- Change: 1.80%
- Total Traded Volume: 344
- Total Buy Quantity: 5,569
- Total Sell Quantity: 3,755
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 628.20 | 11.00 | 0.00 |
| 629.10 | 9.00 | 0.00 |
| 629.20 | 150.00 | 0.00 |
| 629.30 | 39.00 | 0.00 |
| 630.00 | 713.00 | 0.00 |
| 631.00 | 0.00 | 23.00 |
| 633.00 | 0.00 | 10.00 |
| 633.40 | 0.00 | 20.00 |
| 634.25 | 0.00 | 10.00 |
| 634.45 | 0.00 | 7.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 5569
Total Sell Quantity: 3755
Shareholding Patterns of Supriya Lifescience Limited
Key Trade Statistics of Supriya Lifescience Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 2.84 |
| Traded Value (₹ Cr.) | 18.23 |
| Total Market Cap (₹ Cr.) | 5,150.90 |
| Free Float Market Cap (₹ Cr.) | 808.64 |
| Impact cost | 0.09 |
| Quantity Traded | 283,836.00 |
| Deliverable Quantity | 108,629.00 |
| % of Quantity to Traded | 38.27 |
| Security VaR | 21.36 |
| Index VaR | N/A |
| VaR Margin | 21.36 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 24.86 |
| Face Value | 2 |
Key Price Statistics of Supriya Lifescience Limited
The 52-week high for Supriya Lifescience Limited was ₹835.20, recorded on 04-Dec-2024. On the other hand, the 52-week low stands at ₹305.50, with the lowest value recorded on 13-Mar-2024.
The upper band for trading is ₹753.80, and the lower band is ₹502.60. The price band is 20%.
The stock's daily volatility stands at 3.23, while the annualized volatility is 61.71. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (04-Dec-2024) | 835.20 |
| 52 Week Low (13-Mar-2024) | 305.50 |
| Upper Band | 753.80 |
| Lower Band | 502.60 |
| Price Band (%) | 20 |
| Daily Volatility | 3.23 |
| Annualised Volatility | 61.71 |
| Tick Size | 0.05 |
Key Securities Statistics of Supriya Lifescience Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 28-Dec-2021 |
| Adjusted P/E | 28.97 |
| Symbol P/E | 28.97 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Supriya Lifescience Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Supriya Lifescience Limited
| Subject | Date |
|---|---|
| Board Meeting Intimation | 05-Mar-2025 |
| Board Meeting Intimation | 05-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 26-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 26-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 26-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 25-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 18-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Feb-2025 |
Corporate Actions of Supriya Lifescience Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Annual General Meeting/Dividend - Rs 0.80 Per Share | 20-Sep-2024 |
| 2 | Annual General Meeting/Dividend - Re 0.60 Per Share | 15-Sep-2023 |
| 2 | Annual General Meeting/Dividend - Re 0.60 Per Share | 01-Sep-2022 |
Board Meetings of Supriya Lifescience Limited
Financial Results of Supriya Lifescience Limited
Company Directory of Supriya Lifescience Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | 207/208 UDYOG BHAVAN SONAWALA ROAD GOREGAON EAST |
MUMBAI |
| N/A | Registered Office | 207/208 UDYOG BHAVAN SONAWALA ROAD GOREGAON EAST |
MUMBAI |
| N/A | Transfer Agent | C 101 247 Park 1st Floor L B S Marg Vikhroli West |
MUMBAI |
Insider Trading of Supriya Lifescience Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Saloni Satish Wagh | 0 | Sell |
| 7(2) | Shivani Satish Wagh | 0 | Buy |
| 7(2) | Satish Waman Wagh | 2472864 | Buy |
| 7(2) | Satish Waman Wagh | 2488999 | Buy |
| 7(2) | Satish Waman Wagh | 1629526 | Buy |
| 7(2) | Satish Waman Wagh | 407381 | Buy |
| 7(2) | Satish Waman Wagh | 396115 | Buy |
| 7(2) | Satish Waman Wagh | 1584460 | Buy |
Annual Reports of Supriya Lifescience Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Supriya Lifescience Limited | 2023 | 2024 | |
| Supriya Lifescience Limited | 2022 | 2023 | |
| Supriya Lifescience Limited | 2021 | 2022 |
Investor Complaints of Supriya Lifescience Limited
Event Calendar of Supriya Lifescience Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Supriya Lifescience Limited has informed the Exchange about Board Meeting to be held on 12-Aug-2022 to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2022. This is further to inform you that with reference to our letter dated June 29, 2022 and in accordance with the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company￢ﾀﾙs Code of Conduct for Prevention of Insider Trading, the 'Trading Window￢ﾀﾙ for dealing in the securities of the Company shall continue to remain closed till 48 hours after announcement of Unaudited Financial Results for the quarter ended June 30, 2022.Kindly take the above said information on your records. |
| Financial results | Supriya Lifescience Limited has informed the Exchange about Board Meeting to be held on 10-Nov-2022 to consider financial statements for the quarter and half year ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Dividend | To consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2023 and to recommend dividend, if any, for the financial year ended March 31, 2023. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024. |
| Other business matters | Subject: Intimation of Board Meeting for appointment of Company Secretary and Compliance Officer of the Company.With reference to above subject matter and pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Monday, March 10, 2025 at 11.30 a.m at the registered office of the Company to consider and transact the following businesses: 1. Appointment of Company Secretary and Compliance Officer of the Company;2. Any other matter with the permission of the chair.Kindly take the above information on your records. |
Share Transfers of Supriya Lifescience Limited
| Company | Period | Reg.7 | Reg.40 |
|---|---|---|---|
| Supriya Lifescience Limited | 31-MAR-2024 | ||
| Supriya Lifescience Limited | 31-MAR-2023 | ||
| Supriya Lifescience Limited | 31-MAR-2022 |
Voting Results of Supriya Lifescience Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 27-SEP-2024 | AGM | To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2024 and the reports of the Board of Directors and Auditors thereon. |
| 27-SEP-2024 | AGM | To approve continuation of directorship of Mr. Dinesh Navnitlal Modi (DIN: 00004556) as a Non-Executive Independent Director beyond the age of 75 Years. |
| 27-SEP-2024 | AGM | To reappoint Mrs. Smita Satish Wagh (DIN: 00833912) as Whole Time Director & Key Managerial Personnel of the Company |
| 27-SEP-2024 | AGM | To ratify the remuneration of Cost Auditors for the FY 2024-25 |
| 27-SEP-2024 | AGM | To appoint a Director in place of Mrs. Smita Satish Wagh (DIN: 00833912) who retires by rotation and, being eligible, offers herself for re-appointment. |
| 27-SEP-2024 | AGM | To declare a Final Dividend on Equity Shares for the Financial Year ended March 31, 2024 |
| 28-JUL-2024 | Postal Ballot | Change in designation and appointment of Dr. Satish Waman Wagh (DIN: 01456982) as Whole Time Director and Key Managerial Personnel designated as Executive Chairman of the Company. |
| 28-JUL-2024 | Postal Ballot | Change in designation and appointment of Ms. Shivani Satish Wagh (DIN: 08491420) as a Joint Managing Director and Key Managerial Personnel of the Company. |
| 28-JUL-2024 | Postal Ballot | Change in designation and appointment of Dr. Saloni Satish Wagh (DIN: 08491410) as a Managing Director and Key Managerial Personnel of the Company. |
| 29-SEP-2023 | AGM | To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 and the reports of the Board of Directors and Auditors thereon. |
| 29-SEP-2023 | AGM | To ratify the remuneration of Cost Auditors for the FY 2023-24 |
| 29-SEP-2023 | AGM | To appoint a Director in place of Ms. Shivani Satish Wagh (DIN: 08491420) who retires by rotation and, being eligible, offers herself for re-appointment. |
| 29-SEP-2023 | AGM | To declare a Final Dividend on Equity Shares for the Financial Year ended March 31, 2023. |
| 31-JUL-2023 | Postal Ballot | Appointment of Mr. Balasaheb Sawant (Din No.07743507) as a Whole Time Director and Key Managerial Personnel of the Company. |
| 22-APR-2023 | Postal Ballot | Appointment of Mr. Manoj Dorlikar (DIN: 09844876) as a Whole Time Director and Key Managerial Personnel of the Company |
| 16-SEP-2022 | AGM | To receive, consider, approve and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022 and the reports of the Board of Directors and Auditors thereon. |
| 16-SEP-2022 | AGM | To ratify the remuneration of Cost Auditors for the FY 2022-23 |
| 16-SEP-2022 | AGM | To ratify the remuneration of Cost Auditors for the FY 2016-17 |
| 16-SEP-2022 | AGM | To ratify the remuneration of Cost Auditors for the FY 2017-18 |
| 16-SEP-2022 | AGM | To approve delivery of documents through a particular mode as may be sought by the member |
FAQs on Supriya Lifescience Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.